IL136442A0 - Triazolo-pyridazine derivatives as ligands for gaba receptors - Google Patents

Triazolo-pyridazine derivatives as ligands for gaba receptors

Info

Publication number
IL136442A0
IL136442A0 IL13644299A IL13644299A IL136442A0 IL 136442 A0 IL136442 A0 IL 136442A0 IL 13644299 A IL13644299 A IL 13644299A IL 13644299 A IL13644299 A IL 13644299A IL 136442 A0 IL136442 A0 IL 136442A0
Authority
IL
Israel
Prior art keywords
triazolo
ligands
pyridazine derivatives
gaba receptors
gaba
Prior art date
Application number
IL13644299A
Other languages
English (en)
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9801233.9A external-priority patent/GB9801233D0/en
Priority claimed from GBGB9821517.1A external-priority patent/GB9821517D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of IL136442A0 publication Critical patent/IL136442A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13644299A 1998-01-21 1999-01-13 Triazolo-pyridazine derivatives as ligands for gaba receptors IL136442A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9801233.9A GB9801233D0 (en) 1998-01-21 1998-01-21 Therapeutic agents
GBGB9821517.1A GB9821517D0 (en) 1998-10-02 1998-10-02 Therapeutic agents
PCT/GB1999/000103 WO1999037644A1 (en) 1998-01-21 1999-01-13 Triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (1)

Publication Number Publication Date
IL136442A0 true IL136442A0 (en) 2001-06-14

Family

ID=26312988

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13644299A IL136442A0 (en) 1998-01-21 1999-01-13 Triazolo-pyridazine derivatives as ligands for gaba receptors

Country Status (24)

Country Link
US (2) US6579875B1 (cs)
EP (1) EP1049696A1 (cs)
JP (1) JP2002501066A (cs)
KR (1) KR20010034257A (cs)
CN (1) CN1110498C (cs)
AU (1) AU748737B2 (cs)
BG (1) BG104671A (cs)
BR (1) BR9906905A (cs)
CA (1) CA2315763A1 (cs)
CZ (1) CZ290883B6 (cs)
EA (1) EA002755B1 (cs)
EE (1) EE200000430A (cs)
GE (1) GEP20032868B (cs)
HR (1) HRP20000492A2 (cs)
HU (1) HUP0100575A3 (cs)
IL (1) IL136442A0 (cs)
IS (1) IS5540A (cs)
MX (1) MXPA00007135A (cs)
NO (1) NO315516B1 (cs)
NZ (1) NZ504870A (cs)
PL (1) PL341652A1 (cs)
SK (1) SK10922000A3 (cs)
WO (1) WO1999037644A1 (cs)
YU (1) YU43800A (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010034257A (ko) * 1998-01-21 2001-04-25 더블유. 지. 콜 Gaba 수용체에 대한 리간드로서 트리아졸로-피리다진유도체
GB9929685D0 (en) 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0017543D0 (en) 2000-07-17 2000-09-06 Merck Sharp & Dohme Therapeutic agents
WO2005058860A1 (ja) * 2003-12-19 2005-06-30 Ube Industries, Ltd. 4−置換又は非置換テトラヒドロピラン−4−カルボン酸化合物又はそのエステル化合物の製法
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
LT1966214T (lt) * 2005-12-21 2017-02-10 Janssen Pharmaceutica N.V. Triazolopiridazinai kaip tirozino kinazės moduliatoriai
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2123619A1 (de) 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
JP5183808B2 (ja) * 2008-08-29 2013-04-17 コンサート ファーマシューティカルズ インコーポレイテッド 置換トリアゾロ−ピリダジン誘導体
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8501738B2 (en) * 2009-06-23 2013-08-06 Concert Pharmaceuticals, Inc. Substituted triazolo-pyridazine derivatives
RS56410B1 (sr) 2009-07-27 2018-01-31 Gilead Sciences Inc Fuzionisana heterociklična jedinjenja kao modulatori jonskih kanala
CN107050456B (zh) 2010-09-28 2022-08-12 加利福尼亚大学董事会 治疗代谢综合征相关疾病的gaba激动剂和治疗或预防i型糖尿病的gaba组合
PL2707361T3 (pl) 2011-05-10 2018-01-31 Gilead Sciences Inc Skondensowane związki heterocykliczne stosowane jako modulatory kanału sodowego
NO3175985T3 (cs) 2011-07-01 2018-04-28
TWI622583B (zh) 2011-07-01 2018-05-01 基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
GB201321745D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
AU2017228333C1 (en) 2016-02-29 2022-03-10 Dana-Farber Cancer Institute, Inc. Stapled intracellular-targeting antimicrobial peptides to treat infection
CN107344936B (zh) * 2016-05-06 2022-06-03 上海赛默罗生物科技有限公司 三唑哒嗪类衍生物、其制备方法、药物组合物和用途
JP7305614B2 (ja) 2017-07-19 2023-07-10 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド 抗生物質耐性細菌感染症の処置のための安定化抗菌ペプチド

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1080712A (en) * 1976-09-22 1980-07-01 Jay D. Albright Hypotensive agents
US4230705A (en) 1976-09-22 1980-10-28 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
US4112095A (en) * 1976-10-07 1978-09-05 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
PH12424A (en) * 1976-10-26 1979-02-15 American Cyanamid Co Method of treating anxiety in mammals
US4260755A (en) 1979-10-31 1981-04-07 American Cyanamid Company Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines
US4260756A (en) * 1979-11-15 1981-04-07 American Cyanamid Company 6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines
PH21834A (en) * 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
IT1194310B (it) 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
US4654343A (en) 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
YU2899A (sh) * 1996-07-25 2000-03-21 Merck Sharp & Dohme Limited Supstituisani triazolo-piridazin derivati kao ligandi za gaba receptore
KR20010034257A (ko) * 1998-01-21 2001-04-25 더블유. 지. 콜 Gaba 수용체에 대한 리간드로서 트리아졸로-피리다진유도체

Also Published As

Publication number Publication date
AU2065799A (en) 1999-08-09
EP1049696A1 (en) 2000-11-08
HRP20000492A2 (en) 2000-12-31
NO20003730D0 (no) 2000-07-20
YU43800A (sh) 2002-12-10
JP2002501066A (ja) 2002-01-15
CA2315763A1 (en) 1999-07-29
EE200000430A (et) 2001-12-17
SK10922000A3 (sk) 2001-03-12
GEP20032868B (en) 2003-01-27
BR9906905A (pt) 2000-10-10
US6579875B1 (en) 2003-06-17
IS5540A (is) 2000-06-16
BG104671A (en) 2001-05-31
HUP0100575A3 (en) 2003-03-28
CN1288465A (zh) 2001-03-21
PL341652A1 (en) 2001-04-23
NZ504870A (en) 2002-11-26
HUP0100575A2 (hu) 2001-09-28
CZ20002691A3 (cs) 2000-12-13
MXPA00007135A (es) 2002-11-07
NO315516B1 (no) 2003-09-15
US6828322B2 (en) 2004-12-07
KR20010034257A (ko) 2001-04-25
CN1110498C (zh) 2003-06-04
EA002755B1 (ru) 2002-08-29
CZ290883B6 (cs) 2002-11-13
EA200000783A1 (ru) 2000-12-25
AU748737B2 (en) 2002-06-13
US20040063714A1 (en) 2004-04-01
WO1999037644A1 (en) 1999-07-29
NO20003730L (no) 2000-09-20

Similar Documents

Publication Publication Date Title
HUP0100575A3 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
AU2002232768A1 (en) Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
AP2003002818A0 (en) Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
GB0027773D0 (en) Gaba B receptors
AU2002215100A1 (en) Imidazo-pyrimidine derivatives as ligands for gaba receptors
IL141226A0 (en) 1h-imidazopyridine derivatives
PL345540A1 (en) Thiobenzimidazole derivatives
HRP990011B1 (en) Benzosulfone derivatives
AP2001002071A0 (en) Phenyl yanthine derivatives
GB9910384D0 (en) Alpha-ketoamide derivatives
AU2217200A (en) 2-amino-9-alkylpurines: gaba brain receptor ligands
PL349354A1 (en) Substituted phenethylamine derivatives
AU4439801A (en) Pyrazolo-triazine derivatives as ligands for gaba receptors
AU5047399A (en) Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition
EG23802A (en) 2-Phenylpyran-4-one derivatives
GB9815542D0 (en) Bicyclohexane derivatives
GB9827729D0 (en) Thieno-indole derivatives
HK1030605A (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
ZA976591B (en) Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
ZA993845B (en) Triazolo-pyridazine derivatives as ligands for gaba receptors.
EP1061912A4 (en) PHENANTHROFURANDERIVATE
HK1019593A (en) Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
AU2653499A (en) Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
TW353304U (en) Improved structure for accessories